Literature DB >> 19165523

Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia.

Dagmar Koethe1, Laura Kranaster, Carolin Hoyer, Sonja Gross, Miriam A Neatby, Frauke Schultze-Lutter, Stephan Ruhrmann, Joachim Klosterkötter, Martin Hellmich, F Markus Leweke.   

Abstract

The binocular depth inversion illusion test (BDII) represents a sensitive measure of impaired visual information processing that manifests in various experimental and naturally occurring psychotic states. This study explores impairment of visual processing in different major psychiatric diseases investigating 313 subjects, suffering of either an initial prodromal state of psychosis (IPS) or a first-episode, antipsychotic-naïve paranoid schizophrenia (SZ-N) as well as short-term antipsychotically treated schizophrenia (SZ-T), major depression (MDD), bipolar disorder (BD), dementia (D), and healthy controls (HC). Patients suffering from either IPS, SZ-N or a SZ-T showed significantly higher scores of BDII compared to HC, indicating that visual processing is already disturbed at an early state of the disease. For MDD, BD and D no statistically significant difference was found compared to HC. As the identification of individuals at high risk for developing schizophrenia relies on rating scales assessing subtle, pre-psychotic psychopathology, it would be of interest to have more diagnostic criteria available, testing, e.g. cognitive and perceptual impairment. We therefore analysed the receiver operating characteristic (ROC) curve, testing prodromal cases versus a clinically relevant sample of non-psychotic patients and controls, which included HC as well as the groups of patients suffering from MDD, BD or D revealing a AUC of 0.70. Thus, the BDII may be useful as an additional neuropsychological test for assessment of patients at high risk for developing schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19165523     DOI: 10.1007/s00406-008-0851-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

1.  Reduced binocular depth inversion in regular cannabis users.

Authors:  David M Semple; Fiona Ramsden; Andrew M McIntosh
Journal:  Pharmacol Biochem Behav       Date:  2003-07       Impact factor: 3.533

2.  Antibodies to infectious agents in individuals with recent onset schizophrenia.

Authors:  F Markus Leweke; Christoph W Gerth; Dagmar Koethe; Joachim Klosterkötter; Inna Ruslanova; Bogdana Krivogorsky; E Fuller Torrey; Robert H Yolken
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-02       Impact factor: 5.270

3.  Impaired central error-correcting behavior in schizophrenia.

Authors:  R C Malenka; R W Angel; B Hampton; P A Berger
Journal:  Arch Gen Psychiatry       Date:  1982-01

4.  Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man.

Authors:  F M Leweke; U Schneider; M Thies; T F Münte; H M Emrich
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

5.  Reduced binocular depth inversion in schizophrenic patients.

Authors:  U Schneider; M Borsutzky; J Seifert; F M Leweke; T J Huber; J D Rollnik; H M Emrich
Journal:  Schizophr Res       Date:  2002-01-01       Impact factor: 4.939

6.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

7.  Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria.

Authors:  L J Phillips; A R Yung; P D McGorry
Journal:  Aust N Z J Psychiatry       Date:  2000-11       Impact factor: 5.744

8.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

9.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Shona Francey; Elizabeth M Cosgrave; Dominic Germano; Jenny Bravin; Tony McDonald; Alison Blair; Stephen Adlard; Henry Jackson
Journal:  Arch Gen Psychiatry       Date:  2002-10

10.  Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Authors:  Michael Riedel; Ilja Spellmann; Martin Strassnig; Anette Douhet; Sandra Dehning; Markus Opgen-Rhein; Rosamaria Valdevit; Rolf R Engel; Nikolaus Kleindienst; Norbert Müller; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

View more
  23 in total

1.  Failures in learning-dependent predictive perception as the key cognitive vulnerability to psychosis in schizophrenia.

Authors:  Richard S E Keefe; Michael S Kraus; Ranga R Krishnan
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

Review 2.  The endocannabinoid system as a target for modelling psychosis.

Authors:  Dagmar Koethe; Carolin Hoyer; F Markus Leweke
Journal:  Psychopharmacology (Berl)       Date:  2009-06-16       Impact factor: 4.530

Review 3.  Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.

Authors:  Jennifer K Forsyth; David A Lewis
Journal:  Trends Cogn Sci       Date:  2017-07-25       Impact factor: 20.229

4.  Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients.

Authors:  Cathrin Rohleder; Dagmar Koethe; Stefan Fritze; Cristina E Topor; F Markus Leweke; Dusan Hirjak
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-03-19       Impact factor: 5.270

5.  Vision science and schizophrenia research: toward a re-view of the disorder. Editors' introduction to special section.

Authors:  Steven M Silverstein; Brian P Keane
Journal:  Schizophr Bull       Date:  2011-07       Impact factor: 9.306

Review 6.  Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

Authors:  Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt
Journal:  J Child Psychol Psychiatry       Date:  2010-02-26       Impact factor: 8.982

Review 7.  Neurocognitive indicators of clinical high-risk states for psychosis: a critical review of the evidence.

Authors:  Ralf Pukrop; Joachim Klosterkötter
Journal:  Neurotox Res       Date:  2010-04-20       Impact factor: 3.911

8.  Reduced depth inversion illusions in schizophrenia are state-specific and occur for multiple object types and viewing conditions.

Authors:  Brian P Keane; Steven M Silverstein; Yushi Wang; Thomas V Papathomas
Journal:  J Abnorm Psychol       Date:  2013-05

9.  18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia.

Authors:  Emilio Fernandez-Egea; Eduard Parellada; Francisco Lomeña; Carles Falcon; Javier Pavia; Anna Mane; Guillermo Horga; Miguel Bernardo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-05-19       Impact factor: 5.270

10.  Visual context processing dysfunctions in youth at high risk for psychosis: Resistance to the Ebbinghaus illusion and its symptom and social and role functioning correlates.

Authors:  Vijay A Mittal; Tina Gupta; Brian P Keane; Steven M Silverstein
Journal:  J Abnorm Psychol       Date:  2015-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.